Quick Answer
RESMED INC reported Operating Income of $1.69 billion for fiscal year 2025.
RESMED INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $1.69B | +27.7% |
| 2024 | $1.32B | +16.6% |
| 2023 | $1.13B | +13.2% |
| 2022 | $1.00B | +10.7% |
| 2021 | $903.68M | +11.6% |
| 2020 | $809.66M | +39.8% |
| 2019 | $579.26M | +6.9% |
| 2018 | $541.83M | +27.3% |
| 2017 | $425.80M | -0.7% |
| 2016 | $428.95M | +4.8% |
| 2015 | $409.24M | +1.0% |
| 2014 | $405.09M | +14.2% |
| 2013 | $354.82M | +20.5% |
| 2012 | $294.41M | +10.3% |
| 2011 | $266.92M | +11.0% |
| 2010 | $240.38M | +26.3% |
| 2009 | $190.31M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $491.66M | +17.8% | +10.1% |
| September 30, 2025 | $446.54M | +15.3% | +4.8% |
| March 31, 2025 | $426.27M | +13.8% | +2.2% |
| December 31, 2024 | $417.24M | +51.7% | +7.7% |
| September 30, 2024 | $387.31M | +34.0% | +3.4% |
| March 31, 2024 | $374.58M | +24.6% | +36.2% |
| December 31, 2023 | $275.09M | -1.8% | -4.8% |
| September 30, 2023 | $289.00M | +4.8% | -3.9% |
- RESMED INC showed an increase of +27.7% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, RESMED INC’s operating income has grown by 785.6% (from $190.31 million to $1.69 billion).
- The most recent figure is from RESMED INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: